Demographics (1)
- Age.group - Patient age at date on study, marked in 10 year group (phv00258582.v1.p1)
Disease Events (17)
- AFFECTION_STATUS - Case control status of the subject. All subjects are patients with Stage I-III breast cancer. (phv00258565.v1.p1)
- Breast.Nodal.CR.all - Pathological complete response in breast and nodes (path-CR) after 24 weeks of chemo-therapy or the patient's regimen. (phv00258572.v1.p1)
- Clinical.Molecular.Subtype - Clinical molecular tumor type, based on baseline Ki67 results, estrogen receptor level and HER2 status (by IHC or FISH) (phv00258573.v1.p1)
- Estrogen.receptor - Estrogen Receptor level (phv00258578.v1.p1)
- HER2.FISH - HER2 results by Fish (phv00258581.v1.p1)
- HER2.IHC - HER2 results by IHC (phv00258580.v1.p1)
- HISTOLOGIC_TYPE - Cell or tissue type or subtype of sample (phv00258587.v1.p1)
- IS_TUMOR - Tumor status (phv00258586.v1.p1)
- Ki67Sensitivity - Was tumor sensitive to chemo decreasing significantly by Ki67 measure? (phv00258577.v1.p1)
- N.stage - Nodal stage, based on if tumor spread to lymph nodes by breast and, if so, how many nodes are affected (phv00258575.v1.p1)
- Percentage.tumor.cells.baseline - Lab estimate of tumor percentage at baseline (phv00258576.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00258589.v1.p1)
- Progesterone.receptor - Progesterone Receptor level (phv00258579.v1.p1)
- T.stage - Tumor stage, based on size and spread to skin or chest wall under breast (phv00258574.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00258591.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00258590.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00258592.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00258585.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00258584.v1.p1)
- COMMENTS - Description of sequencing preparation or alignment exceptions (phv00258595.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00258564.v1.p1)
- LANE_PORTION - Portion of sequencing lane taken by the sample (phv00258594.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00258588.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00258583.v1.p1)
- SAMPLE_ID - Sample ID (phv00258567.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00258568.v1.p1)
- SAMPLE_USE - Sample Use (phv00258570.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00258593.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00258569.v1.p1)
- Subject_ID - Subject ID (phv00258571.v1.p1)
- Subject_ID - Subject ID (phv00258563.v1.p1)
- SUBJECT_ID - Subject ID (phv00258566.v1.p1)